newsfilter
← Latest News
GlobeNewswire·

Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering

GRAND CAYMAN, Cayman Islands, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion Therapeutics" or the "Company"), a clinical-stage biotechnology company pioneering